Materialise NV: Materialise Reports Second Quarter and Half-Year 2026 Results
Materialise NV reported Q2 2026 revenue of 70,073 kEUR, up 8.1% YoY. Adjusted EBITDA rose 15.7% to 9,593 kEUR, and net profit increased to 3,331 kEUR. Medical segment revenue grew 12.2%, while Software segment revenue declined 2.7%. H1 2026 revenue was 136,349 kEUR, up 3.9% YoY, with adjusted EBITDA up 22.2% to 17,642 kEUR.
How this was made
The 30-second read
Why it matters
The earnings beat and strong cash generation suggest potential upside, but mixed segment performance warrants caution.
Market read
Earnings release provides fresh data for traders; modest scale but first‑report status makes it actionable.
What to watch
Share buyback size and cash position could support near‑term price stability.
Background
Materialise NV reported Q2 2026 and six‑month results, highlighting revenue growth, higher EBITDA, and share buybacks.
Market effects
3D printing and medical device sector may see modest uplift from Materialise's improved profitability.
European tech and industrial markets could react positively to the earnings beat.
Limited; primarily impacts European and niche additive‑manufacturing investors.
Counterpoint
Despite earnings beat, the decline in software segment revenue may signal longer‑term headwinds.
Key entities
- CompanyMaterialise NV
European 3D‑printing and medical device firm reporting earnings.




